The Washington Cannabis Summit is crafted with the goal of positioning WA State as a powerful thought leader in the industry. It is designed to challenge the current state of affairs with Cannabis legislation, research and education. We push the envelope of the conversation past current problems, into a realm where we openly discuss opportunities for the future of the industry. As leaders we not only have the opportunity, but the responsibility, to craft a better future. This starts with intelligent dialogue about where we are, where we’ve been, where we want to go and how we intend to get there.
With more and more states and countries choosing to legalize, it’s important to have foresight, to look at long-term strategies in order to position Washington as a competitive and socially responsible contributor. This can only be accomplished by coming together, being visionary and by working with each other to create sustainable and successful industries.
The audience of the summit includes legislators, policy makers, government employees, business owners, and advocates. Additionally, the speakers, along with the questions from attendees, will both inspire and better connect you with professionals, public servants, academics and citizens who share a commitment to improving the burgeoning cannabis industry.
Dr. Karyemaitre Aliffe is a multilingual physician-scientist who brings life to science, and vitality to our concepts of medicine. His 35+ years experience in natural products research and discovery spirals the globe, from Ivy League Academia and Silicon Valley Biotech, to the remote healing forests of the Amazon, Australia and Africa. From teaching appointments at Harvard and Stanford, Dr. Aliffe has since been welcomed to over 50 countries as a keynote speaker and guest lecturer, giving insightful presentations to governments and institutions, corporations and executives, health-focused professionals and community groups worldwide.
Dr. Aliffe is presently Chair, Executive Officer at Praxigen Biomedia and Noobiome Clinical Sciences (non-profit research and education). He leads an expert Natural Health Product Development Team, applying translational medicine and integrative neurophysiology to expand the utility of cannabis-
based formulations unto enhancement of global human life in fitness and longevity.
Attorney General ,
Bob Ferguson is Washington State’s 18th Attorney General. As the state’s chief legal officer, Bob is committed to protecting the people of Washington against powerful interests that don’t play by the rules. He is a fourth-generation Washingtonian, a graduate of the University of Washington and New York University law school. Bob and his wife, Colleen, are the proud parents of 10-year-old twins, Jack and Katie.
Canadian-American comedian, actor, writer, director, musician and cannabis rights activist
Throughout his life and career Tommy Chong has been an advocate for legalizing cannabis both medically and recreationally. His movies, live performances and many other appearances all speak to that advocacy in one form or another. Tommy Chong was a pioneer in educating the public about the positive side of cannabis and still pursues this goal passionately. He has appeared on all the major networks and most of the large cable franchises discussing the subject of legalization and recounting his own personal use of medical cannabis in a recent bout with prostate cancer which is now in remission. Tommy Chong supports many advocacy groups nationwide who are trying to bring legislation into their states to legalize the medical and the recreational use of cannabis along with supporting groups that seek federal legislation. On a personal level, Tommy donates a great deal of his time, personage and public influence to help many such organizations reach their goals.
Cannabis Science & Community Development,
Amanda Reiman was the Manager of Marijuana Law and Policy at the Drug Policy Alliance, where she works to develop DPA’s marijuana reform work as it relates to litigation, legislative and initiative drafting, campaign strategy, policy advocacy, media relations, fundraising, and public education in the local, state, federal, and international jurisdictions in which DPA is active. Reiman joined DPA in 2012 after working with Berkeley Patients Group, a renowned medical marijuana dispensary, as director of research and patient services. Reiman served as the first chairwoman of the Medical Cannabis Commission for the City of Berkeley, currently serves on the Cannabis Regulatory Commission for the city of Oakland, and has consulted with various cities, states, and nations on the development of medical marijuana policy. Reiman is currently a lecturer in the School of Social Welfare at the University of California, Berkeley, where she earned her PhD in Social Welfare.
President and Site Principal Investigator ,
The Scottsdale Research Institute
Dr. Suzanne A. Sisley practices medicine in Scottsdale, AZ and specializes in Internal Medicine and Psychiatry. She is widely known for her research into potential medical uses of marijuana to treat veterans diagnosed with PTSD. Dr. Sisley’s research is supported by the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based nonprofit organization. Dr. Sisley serves as Principal Investigator for the only FDA-approved randomized controlled trial looking at use of whole-plant marijuana (grown by NIDA) in combat veterans with treatment-resistant post-traumatic stress disorder PTSD.